234 related articles for article (PubMed ID: 21447966)
21. Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a study.
Paul C; Sans B; Suarez F; Casassus P; Barete S; Lanternier F; Grandpeix-Guyodo C; Dubreuil P; Palmérini F; Mansfield CD; Gineste P; Moussy A; Hermine O; Lortholary O
Am J Hematol; 2010 Dec; 85(12):921-5. PubMed ID: 21108325
[TBL] [Abstract][Full Text] [Related]
22. [Risk factors for low birth weight and intrauterine growth retardation in Santiago, Chile].
Vega J; Sáez G; Smith M; Agurto M; Morris NM
Rev Med Chil; 1993 Oct; 121(10):1210-9. PubMed ID: 8191127
[TBL] [Abstract][Full Text] [Related]
23. Systemic mastocytosis with diffuse cutaneous involvement and haematological disease presenting in utero treated unsuccessfully with vincristine.
Angus J; Leach IH; Grant J; Ravenscroft JC
Clin Exp Dermatol; 2008 Jan; 33(1):36-9. PubMed ID: 17983456
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous mastocytosis in Thai children.
Singalavanija S; Limpongsanurak W
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S143-6. PubMed ID: 19253510
[TBL] [Abstract][Full Text] [Related]
25. The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.
Jennings S; Russell N; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C
J Allergy Clin Immunol Pract; 2014; 2(1):70-6. PubMed ID: 24565772
[TBL] [Abstract][Full Text] [Related]
26. Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature.
Lange M; Niedoszytko M; Nedoszytko B; Łata J; Trzeciak M; Biernat W
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1565-71. PubMed ID: 22092511
[TBL] [Abstract][Full Text] [Related]
27. [Mastocytosis and pregnancy].
Maatouk A; Morel O; Jean J; Vial F; Welter E; Muhlstein J; Monceau É
J Gynecol Obstet Biol Reprod (Paris); 2013 Apr; 42(2):117-22. PubMed ID: 22459804
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy and obstetrical outcomes in pseudoxanthoma elasticum.
Bercovitch L; Leroux T; Terry S; Weinstock MA
Br J Dermatol; 2004 Nov; 151(5):1011-8. PubMed ID: 15541079
[TBL] [Abstract][Full Text] [Related]
29. Refined Treatment Response Criteria for Indolent Systemic Mastocytosis Proposed by the ECNM-AIM Consortium.
Pyatilova P; Akin C; Alvarez-Twose I; Arock M; Bonadonna P; Brockow K; Butterfield JH; Broesby-Olsen S; Carter MC; Castells M; George TI; Gotlib J; Greiner G; Gülen T; Hartmann K; Hermine O; Horny HP; Jawhar M; Lange M; Lyons JJ; Maurer M; Metcalfe DD; Nedoszytko B; Niedoszytko M; Orfao A; Reiter A; Schwaab J; Sotlar K; Sperr WR; Triggiani M; Valent P; Siebenhaar F
J Allergy Clin Immunol Pract; 2022 Aug; 10(8):2015-2024. PubMed ID: 35724950
[TBL] [Abstract][Full Text] [Related]
30. Pathogenesis, clinical features, and treatment advances in mastocytosis.
Pardanani A; Akin C; Valent P
Best Pract Res Clin Haematol; 2006; 19(3):595-615. PubMed ID: 16781490
[TBL] [Abstract][Full Text] [Related]
31. Mastocytosis.
Metcalfe DD
Novartis Found Symp; 2005; 271():232-42; discussion 242-9. PubMed ID: 16605139
[TBL] [Abstract][Full Text] [Related]
32. [Mastocytosis and anaesthesia].
Dewachter P; Mouton-Faivre C; Cazalaà JB; Carli P; Lortholary O; Hermine O
Ann Fr Anesth Reanim; 2009 Jan; 28(1):61-73. PubMed ID: 19097849
[TBL] [Abstract][Full Text] [Related]
33. Current approaches to the diagnosis and treatment of systemic mastocytosis.
Bains SN; Hsieh FH
Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640
[TBL] [Abstract][Full Text] [Related]
34. Mast Cell Disorders In Drug Hypersensitivity.
Bonadonna P; Bonifacio M; Zanotti R
Curr Pharm Des; 2016; 22(45):6862-6869. PubMed ID: 27779084
[TBL] [Abstract][Full Text] [Related]
35. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
36. Anaesthetic management of emergency caesarean section in a parturient with systemic mastocytosis.
Ulbrich F; Engelstädter H; Wittau N; Steinmann D
Int J Obstet Anesth; 2013 Jul; 22(3):243-6. PubMed ID: 23707036
[TBL] [Abstract][Full Text] [Related]
37. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
[TBL] [Abstract][Full Text] [Related]
38. Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis.
Hahn HP; Hornick JL
Am J Surg Pathol; 2007 Nov; 31(11):1669-76. PubMed ID: 18059223
[TBL] [Abstract][Full Text] [Related]
39. Mastocytosis complicating pregnancy.
Worobec AS; Akin C; Scott LM; Metcalfe DD
Obstet Gynecol; 2000 Mar; 95(3):391-5. PubMed ID: 10711550
[TBL] [Abstract][Full Text] [Related]
40. [The clinical spectrum of mastocytosis].
Langer K; Wolff K
Hautarzt; 1990 Apr; 41(4):188-95. PubMed ID: 2192996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
